Oral Delivery of Mycobacterium bovis BCG in a Lipid Formulation Induces Resistance to Pulmonary Tuberculosis in Mice

A lipid-based formulation has been developed for oral delivery of Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine. The formulated M. bovis BCG was fed to BALB/c mice to test for immune responses and protection against M. bovis infection. The immune responses included antigen-specific cytok...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Infect Immun
Päätekijät:	Aldwell, Frank E., Tucker, Ian G., de Lisle, Geoffrey W., Buddle, Bryce M.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2003
Aiheet:	Microbial Immunity and Vaccines
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC143408/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12496154/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.71.1.101-108.2003
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!